Lessons Learned: ERP for Pharma Can Streamline Safety Recalls
In the pharmaceutical industry, safety recalls are a critical part of maintaining public health and corporate reputation. Recent recalls by major pharmaceutical players Sun Pharma and Lupin have highlighted the critical importance of robust recall procedures in the pharmaceutical sector. Whether due to "failed impurities/degradation specifications" (Sun Pharma) or "failed dissolution specifications" (Lupin), these recalls have significant implications for both patients and companies. Sun Pharma, based in Mumbai, is recalling 96,192 bottles of Liothyronine Sodium Tablets in the US, posing potential risks to patients with underactive thyroid conditions. Concurrently, Lupin is recalling penicillamine tablets in the US, affecting patients with rheumatoid arthritis and Wilson's disease, due to "failed dissolution specifications." This situation underscores the urgent need for efficient drug recall processes. In this blog, we'll analyse the recent reca